[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371874-105":59,"doc-detail-371874-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","acoxl-as1s-pan-cancer-dynamics-and-its-proliferative-impact-on-endometrial-endometrioid-carcinoma-research","ACOXL-AS1’s pan-cancer dynamics and its proliferative impact on endometrial endometrioid carcinoma - Research","","Long non-coding RNAs are central to carcinogenesis, yet ACOXL-AS1’s pan-cancer significance and functional mechanism remain insufficiently defined. This study maps ACOXL-AS1 expression, prognostic relevance, and biological effects across multiple malignancies, emphasizing endometrial endometrioid carcinoma. Pan-cancer RNA-seq from TCGA and GTEx links expression with outcomes; EEC cell-line assays test proliferation, migration and invasion, supported by integrated bioinformatics.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/acoxl-as1s-pan-cancer-dynamics-and-its-proliferative-impact-on-endometrial-endometrioid-carcinoma-research/371874/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/acoxl-as1s-pan-cancer-dynamics-and-its-proliferative-impact-on-endometrial-endometrioid-carcinoma-research/371874.png","ImageObject",300,407,{"name":92,"@type":93},"Blitz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was ACOXL-AS1 analyzed across cancers in this study?","Question",{"text":112,"@type":113},"Expression and prognostic associations were assessed using pan-cancer RNA-seq datasets from TCGA and GTEx, linking ACOXL-AS1 levels to clinical outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What experimental methods were used to test the role of ACOXL-AS1 in endometrial endometrioid carcinoma?",{"text":117,"@type":113},"Endometrial endometrioid carcinoma cell lines were engineered for lentivirus-mediated ACOXL-AS1 overexpression, followed by CCK-8, colony formation, and transwell migration/invasion assays.",{"name":119,"@type":110,"acceptedAnswer":120},"What biological effects did ACOXL-AS1 show in the endometrial endometrioid carcinoma context?",{"text":121,"@type":113},"ACOXL-AS1 overexpression inhibited EEC cell proliferation, migration, invasion, and tumor growth in xenograft models, with mechanistic support suggesting regulation of RPA4 via homologous recombination pathways.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371874,1790242992,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Wu et al. BMC Cancer (2025) 25:1522 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-15005-y](https://doi.org/10.1186/s12885-025-15005-y)  \nRESEARCH Open Access  \nACOXL-AS1’s pan-cancer dynamicsand its proliferative impact on endometrial endometrioid carcinoma  \nHongrong Wu 1, Ruilin Lin 1 and Liangli Hong 1*  \nAbstract  \nBackground Long non-coding RNAs (lncRNAs) are critically involved in carcinogenesis; however, the pan-cancer significance and functional mechanisms of ACOXL-AS1 remain largely uncharacterized. This study comprehensively investigates the expression landscape, prognostic value, and biological impact of ACOXL-AS1 across multiple malignancies, with a specific focus on its pro-proliferative role in endometrial endometrioid carcinoma (EEC) . Methods We analyzed ACOXL-AS1 expression and its association with clinical outcomes using pan-cancer RNAseq data from TCGA and GTEx databases. Functional validation was performed in EEC cell lines (HHUA, HEC-1 A) via lentivirus-mediated overexpression, followed by CCK-8, colony formation, and transwell migration/invasion assays. Mechanistic insights were investigated using integrated bioinformatics approaches.  \nResults ACOXL-AS1 was significantly downregulated in most cancers, and higher expression correlated with improved prognosis. Elevated ACOXL-AS1 levels were associated with smaller tumor size, lower disease stage, reduced metastasis, and decreased tumor mutational burden (TMB)/microsatellite instability (MSI) . It also modulated the immunosuppressive tumor microenvironment. Critically, ACOXL-AS1 overexpression significantly inhibited EEC cell proliferation, migration, invasion, and tumor growth in xenograft models. Mechanistically, it may regulate RPA4 expression through the homologous recombination pathway in EEC cells.  \nConclusions ACOXL-AS1 may play a role as a tumor suppressor in endometrial endometrioid carcinoma (EEC), suggesting its potential as a prognostic biomarker and a candidate for further exploration as a therapeutic target. Keywords ACOXL-AS1, Endometrial carcinoma, Cancer progression, Immune evasion  \n*Correspondence: Liangli Hong [hong_liangli@163.com](hong_liangli@163.com)  \n1Department of Pathology, First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nIntroduction  \nLong non-coding RNAs (lncRNAs) have emerged as pivotal regulators in tumorigenesis due to their diverse roles in transcriptional regulation, chromatin remodeling, and post-transcriptional modification [1] . Increasing evidence links lncRNAs to fundamental cancer hallmarks, including uncontrolled proliferation, resistance to cell death, and enhanced migration and invasion [2–5] . While significant progress has been made in elucidating the functions of individual lncRNAs within specific cancer types, a comprehensive understanding of their roles across multiple tumor lineages remains ","cbCaiovIRwutFYZe","https://ap.wps.com/l/cbCaiovIRwutFYZe","pdf",4622841,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"How was ACOXL-AS1 analyzed across cancers in this study?\",\"answer\":\"Expression and prognostic associations were assessed using pan-cancer RNA-seq datasets from TCGA and GTEx, linking ACOXL-AS1 levels to clinical outcomes.\"},{\"question\":\"What experimental methods were used to test the role of ACOXL-AS1 in endometrial endometrioid carcinoma?\",\"answer\":\"Endometrial endometrioid carcinoma cell lines were engineered for lentivirus-mediated ACOXL-AS1 overexpression, followed by CCK-8, colony formation, and transwell migration/invasion assays.\"},{\"question\":\"What biological effects did ACOXL-AS1 show in the endometrial endometrioid carcinoma context?\",\"answer\":\"ACOXL-AS1 overexpression inhibited EEC cell proliferation, migration, invasion, and tumor growth in xenograft models, with mechanistic support suggesting regulation of RPA4 via homologous recombination pathways.\"}]","ACOXL-AS1’s pan-cancer dynamics and its proliferative impact on endometrial endometrioid carcinoma - Research | PDF",1790193080,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f77bdd187c393c58b8f340fc7e7bc33.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5b25bc5dee17a23192f999542ce96a9.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81bac5df536382f4d6b178061523f85b.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e1db617618be085fae2f40da1a46406.webp",980,1306]